Showing results (31-40 of 56) with videos related to
Sort By:
Pageof 6
Radiology|April 25, 2013
Thalamic atrophy is associated with development of clinically definite multiple sclerosisRobert Zivadinov, Eva Havrdová, Niels Bergsland, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2016
A serial 10-year follow-up study of brain atrophy and disability progression in RRMS patientsRobert Zivadinov, Tomas Uher, Jesper Hagemeier, et al.Journal of Lipid Research|December 8, 2016
Serum lipid profile changes predict neurodegeneration in interferon-β1a-treated multiple sclerosis patientsTomas Uher, Kelly Fellows, Dana Horakova, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months laterTomas Uher, Dana Horakova, Michaela Tyblova, et al.Journal of Lipid Research|August 6, 2015
Protective associations of HDL with blood-brain barrier injury in multiple sclerosis patientsKelly Fellows, Tomas Uher, Richard W Browne, et al.Journal of the Neurological Sciences|December 3, 2014
Relationship between gray matter volume and cognitive learning in CIS patients on disease-modifying treatmentTomas Uher, Ralph H B Benedict, Dana Horakova, et al.Journal of Neuroimmunology|May 31, 2011
HLA DRB1*1501 is only modestly associated with lesion burden at the first demyelinating eventDana Horakova, Robert Zivadinov, Bianca Weinstock-Guttman, et al.American Journal of Ophthalmology|May 1, 2018
Progressive Chronic Retinal Axonal Loss Following Acute Methanol-induced Optic Neuropathy: Four-Year Prospective Cohort StudyOlga Nurieva, Pavel Diblik, Pavel Kuthan, et al.Clinical Toxicology (Philadelphia, Pa.)|August 9, 2020
Efficiency of 123I-ioflupane SPECT as the marker of basal ganglia damage in acute methanol poisoning: 6-year prospective studyKaterina Kotikova, David Zogala, Vaclav Ptacnik, et al.Journal of Neuroimmunology|August 7, 2013
Interactions of serum cholesterol with anti-herpesvirus responses affect disease progression in clinically isolated syndromesBianca Weinstock-Guttman, Dana Horakova, Robert Zivadinov, et al.Pageof 6